High expression of autophagy-related gene EIF4EBP1 could promote tamoxifen resistance and predict poor prognosis in breast cancer

doi:10.12998/wjcc.v11.i20.4788

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 20

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3446)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

WORD

HTML

1649

Figures (1-4)

305

Tables (1-1)

367

Sum=2419

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

171

Download

717

Sum=888

Jul 16, 2023 (publication date) through Feb 18, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Clin Cases. Jul 16, 2023; 11(20): 4788-4799
Published online Jul 16, 2023. doi: 10.12998/wjcc.v11.i20.4788

Full Size Figure Download Figure

Figure 2 Immunohistochemical staining for eukaryotic translation initiation factor 4E binding protein 1 in breast cancer tissues. A: Invasive ductal carcinoma; B: Invasive micropapillary carcinoma; C: Invasive lobular carcinoma; D: Normal breast cancer tissues.

Citation: Yang S, Hui TL, Wang HQ, Zhang X, Mi YZ, Cheng M, Gao W, Geng CZ, Li SN. High expression of autophagy-related gene EIF4EBP1 could promote tamoxifen resistance and predict poor prognosis in breast cancer. World J Clin Cases 2023; 11(20): 4788-4799
URL: https://www.wjgnet.com/2307-8960/full/v11/i20/4788.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i20.4788